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The biology of autism cannot yet be
used diagnostically, and so—like most
psychiatric conditions—autism is defined
by behavior [Rett syndrome (Rett’s disor-
der) is diagnosed by incorporating biology,
but it has been moved out of the ‘‘Autism
Spectrum Disorder’’ category in DSM-5].
The two international psychiatric classifi-
cation systems (the Diagnostic and Statis-
tical Manual of Mental Disorders [DSM]
and the International Classification of
Diseases [ICD]) remain useful for making
clinical diagnoses, but each time these
classification systems are revised, the new
definitions inevitably subtly change the
nature of how the conditions are con-
strued. While acknowledging concerns
about issues such as diagnostic inflation
[1] and financial conflicts of interest [2],
DSM-5 is now ‘‘set in stone’’ and will be
published in May 2013. Although this
manual is primarily designed for creating a
common language for clinical practice, it is
also often used in research settings to
define the conditions to be studied. Here
we reflect on what the revision may mean
for research, and for understanding the
nature of autism.
New in DSM-5 is the explicit recogni-
tion of the ‘‘spectrum’’ nature of autism,
subsuming and replacing the DSM-IV
Pervasive Developmental Disorder (PDD)
categorical subgroups of ‘‘autistic disor-
der,’’ ‘‘Asperger’s disorder,’’ ‘‘pervasive
developmental disorder not otherwise
specified,’’ and ‘‘childhood disintegrative
disorder’’ into a single umbrella term
‘‘Autism Spectrum Disorder’’ (ASD).
[Here and throughout we use the term
‘‘ASD’’ because this is what is used in
DSM-5. However, in our publications
over many years we have opted for the
more neutral term ‘‘ASC’’ (Autism Spec-
trum Conditions) to signal that this is a
biomedical diagnosis in which the individ-
ual needs support, and which leaves room
for areas of strength as well as difficulty,
without the somewhat negative overtones
of the term ‘‘disorder,’’ which implies
something is ‘‘broken.’’] DSM-5 charac-
terizes ASD in two behavioral domains
(difficulties in social communication and
social interaction, and unusually restricted,
repetitive behaviors and interests) and is
accompanied by a severity scale to capture
the ‘‘spectrum’’ nature of ASD.
Also new in DSM-5, language develop-
ment/level is treated as separate from
ASD. This means an individual can have
ASD with or without a language disorder.
Finally, DSM-5 proposes a more inclusive
age-of-onset criterion, recognizing that
although symptoms should present in early
childhood, they may not fully manifest
until social demands exceed the capacity
of the individual to cope with them. The
major rationale behind these changes is to
improve reliability [3]. The DSM-5 field
trial in North America has shown that
ASD diagnosis has reasonable test-retest
reliability, with an intraclass Kappa (a
statistical measure of reliability) of 0.69
(95% CI 0.58–0.79) [4].
There have been concerns that the
DSM-5 criteria may be more stringent
than DSM-IV, such that some individuals
who qualified for PDD will not meet the
new ASD criteria. A series of studies
testing the initial [5] and revised draft
ASD criteria [6–12] showed increased
specificity but decreased sensitivity of the
DSM-5 draft compared to DSM-IV, and
suggested relaxation of the threshold (e.g.,
fewer numbers of required symptom
subdomains) to achieve reasonable sensi-
tivity. However, most of these studies
suffer from the weakness of using retro-
spective datasets and tools developed
earlier that may not satisfactorily capture
symptoms now included in DSM-5 [13].
One prospective study tested both DSM-
IV and DSM-5 criteria against the gold
standard of ‘‘best-estimate clinical diagno-
ses’’ and agreed with the ‘‘too-stringent’’
conclusion in a clinical sample [14].
However, another substantially large ret-
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rospective study using data from three
existing datasets found few differences
between the two systems in sensitivity [15].
In brief, these studies all show that
DSM-5 provides better specificity (so
reducing false-positive diagnoses), but at
the expense of potentially reduced sensi-
tivity, especially for older children, adoles-
cents and adults, individuals without
intellectual disability, and individuals
who previously met criteria for diagnoses
of DSM-IV ‘‘Asperger’s disorder’’ or
‘‘pervasive developmental disorder not
otherwise specified.’’ It remains to be seen
in real-life settings how diagnostic practice,
service delivery, and prevalence estimates
will be affected by applying DSM-5 ASD
criteria. In particular, one major nosolog-
ical issue is to what extent individuals
fitting DSM-IV PDD but not DSM-5
ASD diagnoses will end up falling into
the newly created diagnosis of ‘‘Social
(Pragmatic) Communication Disorder’’
[12,16–18]. Clearly more research needs
to be done to provide a thorough and fair
evaluation of this revision.
Highlighting the dimensional nature of
the two cardinal behavioral domains of
ASD, as well as the improved organization
of symptom descriptions, are excellent
features of DSM-5. A unitary label of
‘‘ASD’’ accompanied by individualized
assessment of needs for support will likely
be useful in clinical settings, especially to
guarantee the required levels of support
for all individuals ‘‘on the spectrum’’ who
will benefit from educational, occupation-
al, social, mental health, and medical
interventions (even if they are etiologically,
developmentally, and clinically heteroge-
neous). However, this approach is not
useful for research in general, given the
known massive heterogeneity within such
an omnibus label. Within autism there is a
huge variability in terms of behavior
(symptom severity and combination), cog-
nition (the range of deficits and assets), and
biological mechanisms. Acknowledging
heterogeneity has led to the idea that
there are many ‘‘autisms,’’ with partially
distinct etiologies, nested within the um-
brella term of ‘‘ASD’’ [19]. Therefore, two
critical issues need to be addressed: a
clarification of the meaning(s) of the term
‘‘spectrum’’; and the need for subgroup-
ing.
What Do We Mean by the
Autism ‘‘Spectrum’’?
There are several meanings of the term
‘‘spectrum’’ in relation to autism. The
differences are subtle but nontrivial. DSM-
5 does not tease these apart, but in relation
to future research into the ‘‘autism spec-
trum,’’ it is important to be clear to which
meaning the term ‘‘spectrum’’ refers.
1. ‘‘Spectrum’’ can refer to the dimen-
sional nature of the cardinal features of
autism within the clinical population (i.e.,
differences in the severity and presen-
tation of symptoms among those with a
diagnosis of ASD). This was suggested
in the 1970s, before autism appeared in
DSM-III, when Lorna Wing highlight-
ed the diversity among the cardinal
behavioral domains within autism [20].
2. ‘‘Spectrum’’ can also refer to the
continuity between the general population and
the clinical population. This view of the
spectrum requires the concept of ‘‘au-
tistic traits’’ (sometimes referred to as
‘‘autistic-like traits’’) that run right
through the whole population. Autistic
traits can refer to the individual
features that together comprise the
quantitative variability in the cardinal
behavioral domains defined by DSM/
ICD criteria. Studies using question-
naire measures of autistic traits (e.g.,
the Quantitative Checklist for Autism
in Toddlers [Q-CHAT] [21], the
Childhood Autism Spectrum Test
[CAST] [22], and the Autism Spec-
trum Screening Questionnaire [ASSQ]
[23]) show a continuous distribution of
scores, supporting the concept of a
spectrum extending into the general
population. Underlying autistic traits
are genetic susceptibilities that are
common across the general population
and at the extreme ends [24], and for
clinically defined ASD [25]. ‘‘Autistic
traits’’ can also refer to associated features
not described in DSM/ICD criteria,
exemplified by items within question-
naires such as the Social Responsive-
ness Scale (SRS) [26] (e.g., ‘‘Becomes
upset in a situation with lots of things
going on’’) or the Autism Spectrum
Quotient (AQ) [27] (e.g., ‘‘I tend to
notice details that others do not’’).
These composite measures of autistic
traits (including both cardinal and
associated features) are also continu-
ously (and normally) distributed, and
have been used to characterize the
‘‘broader autism phenotype’’ (BAP)
[28,29]. These traits also show shared
genetic association with clinically de-
fined ASD [30].
3. ‘‘Spectrum’’ can also refer to subgroups
[31,32]. It has been suggested that ‘‘the
autisms’’ may be a useful concept to
reflect the substantial heterogeneity
within the autistic spectrum [19].
DSM-5 has tried to move away from
subgrouping ‘‘to stop trying to ‘carve
meatloaf at the joints’ and instead
recognize the essential shared features
of the autism spectrum while attempt-
ing to individualize diagnosis through
dimensional descriptors’’ (p. 541) [32].
While it is likely that the reliability of
diagnosis will improve by using the
broader ASD label (compared to using
DSM-IV subtypes), to understand the
biology of ‘‘the autisms,’’ it is necessary
to clarify not just the similarities but
also the differences among subgroups.
Subgrouping and the Use of
‘‘Specifiers’’
DSM-5 holds back from listing sub-
groups by recommending the use of
‘‘specifiers’’ to record the severity of
cardinal symptoms, current language and
intellectual ability, onset age and pattern,
and concurrent genetic/medical or envi-
ronmental/acquired conditions [33]. The
use of specifiers is likely to be a valuable
addition. However, there is a need to
grasp the nettle to provide a more fine-
grained taxonomy for research and clinical
purposes (e.g., for access to appropriate
individualized services). We therefore sug-
gest expanding the list of specifiers toward
the identification of clear subgroups.
Table 1 summarizes our preliminary
expanded but nonexhaustive list of speci-
fiers, discussed here:
a. Developmental pattern: Age and pattern
of onset of atypical development
should be recorded. This includes
not only ‘‘regression’’ [34] but also
language onset/development and
atypical social, emotional, communi-
cative, physical and general intellec-
tual development. These developmen-
tal patterns may have etiological
implications. Differences in the trajec-
tories of changes in autistic features
[35,36] may also have etiological
implications, and are relevant to
clinical management and prognosis.
Development of prognostic biomark-
ers (e.g., of language outcome) may be
particularly useful.
b. Sex/gender: There are substantial sex/
gender-specific effects at a variety of
levels (e.g., behavior and cognition
[37,38], genetics [39,40], proteomics
[41], and neuroanatomy [42,43]),
which contribute to heterogeneity.
For this reason, sex/gender should
not just be viewed as a demographic
descriptor but also an important
specifier toward subgrouping ‘‘the
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autisms.’’ In the general population
there is a sex/gender difference in the
distribution of autistic traits [26,44]. If
we view autism as the extreme of a
continuous distribution of autistic
traits in the population, one important
specifier could be a statistical measure
of where an individual lies on a sex/
gender-specific distribution (e.g., per-
centile or z-score). Any statistical
characterization would require sex/
gender-specific norms and thresholds
for defining ASD. There are many
precedents for sex/gender-specific sta-
tistical characterization in other fields
of medicine. For example, ‘‘failure to
thrive’’ is defined using sex-specific
growth curves for infants, and anemia
is defined using sex-specific norms of
serum hemoglobin levels [45]. Cur-
rently, DSM-5 is sex/gender-blind: it
uses identical diagnostic criteria for
ASD for both males and females.
Although it remains an open question
whether sex/gender-specific norms,
thresholds, or criteria should be
adopted, we underscore the impor-
tance of sex/gender to aid future
research into subgrouping, which
may lead to the identification of
important sex/gender-linked mecha-
nisms [46]. This issue is especially
relevant for understanding the male
bias in prevalence and potential
unde r r e cogn i t i on o f f ema l e s
[37,44,47].
c. Clinical phenotypes: DSM-5 recognizes
concurrent medical and neuropsychi-
atric conditions, which of course is
vital as a substantial portion of
individuals with ASD show comor-
bidity. In addition to these, we suggest
ASD could also be specified by other
prototypical clinical subgroups, such as
Asperger syndrome (e.g., defined by Hans
Asperger’s initial report or the Gill-
berg criteria [48]) or Wing’s categori-
zation (of the ‘‘aloof,’’ ‘‘passive,’’
‘‘active but odd,’’ and ‘‘loners’’
groups) [49]. This would allow for
more systematic investigation of these
long-standing rich clinical descrip-
tions, which have not been studied
thoroughly yet. It is of particular
concern that Asperger syndrome is
not specified by DSM-5 given insuffi-
cient research being conducted into
how this may differ from other forms
of autism [50]. In the context of a
relative lack of consensus in definition
[51], research findings of similarities
and differences between ‘‘Asperger
syndrome’’ and so-called ‘‘high-func-
tioning autism (autistic disorder)’’ can
either be interpreted as not supporting
such a distinction [52] or that it is
premature to rule out the separateness
of the two [53]. Providing that the
definition of the diagnosis adopted in
the study is well described, in research
using large samples it should be
straightforward to identify a reliable
signal, and the concern of unsatisfac-
tory interrater reliability [32] may be
alleviated.
d. Cognitive profile: Cognition plays a
pivotal role linking brain and behav-
ior in ASD [54], yet curiously remains
absent in DSM-5. Cognitive specifiers
would be relevant for research into
subgrouping, for discovering biomark-
ers, and for clinical evaluation. While
the variability of intelligence and
structural properties of language (as
well as their development) has long
been acknowledged, and is predictive
of prognosis [55,56], other aspects of
cognition in autism may also be
useful. Examples include social cognition
(e.g., mentalizing/theory of mind,
emotion processing, social orienting
and reward processing), executive func-
tion (e.g., cognitive flexibility, plan-
ning, inhibitory control, attention
shifting), bottom-up perceptual processing
(e.g., global-local perceptual process-
ing, low-level perceptual function and
discrimination), and top-down informa-
tion processing (e.g., ‘‘central coher-
ence,’’ ‘‘systemizing’’—the drive to
analyze and construct rule-based sys-
tems). Although some of the measures
for these cognitive domains still lack
general population norms, this should
not prevent researchers and clinicians
from including a systematic cognitive
assessment focusing on these domains,
for both research into individual
differences and for individualized
service planning.
e. Known genetic correlates: These have the
potential to dissect ‘‘the autisms’’ into
subgroups at the genetic level [57], so
they are vital to record in both
research and clinical settings [58].
This includes identifiable ASD-related
genetic syndromes, chromosomal
anomalies, and rare and highly pen-
etrant de novo and non–de novo
genetic variations (copy number var-
iations and rare genetic variants)
[57,59–61]. Depending on the pattern
of familial aggregation and the nature
of genetic variation (de novo vs. non–
de novo), autism may be further
classified into ‘‘simplex’’ and ‘‘mutli-
plex.’’ In addition, common inherited
variations (i.e., polymorphisms) and
de novo genetic variation of low
penetrance in multiple genes in criti-
cal biochemical and cellular pathways
associated with neurodevelopment
[62] may underlie the autistic spec-
trum that extends on to the general
population. Some of the candidate
genes are listed in Table 1, but we
refer the readers to https://gene.sfari.
org/autdb/Welcome.do for a con-
stantly updating database.
f. Potential environmental contributors: Per-
haps due to the frequently reported
high heritability of autism [63], envi-
ronmental factors and gene-environ-
ment interplay in autism are under-
studied [64] but may also help toward
identification of subgroups. For ex-
ample, social deprivation early in life
[65] or other environmental risk
factor exposure (e.g., teratogens) and
the timing of exposure [66] could be
relevant and should be specified.
It is notable that the US National
Institute of Mental Health (NIMH) has
initiated the Research Domain Criteria
[67] (with many of the above domains
covered) to provide a system independent
of DSM and ICD. Such initiatives are
important to move toward identification of
subgroups in a research context and for
how they cut across DSM/ICD diagnostic
categories. Such a system could provide a
basis for identifying biological mechanisms
that may or may not respect the DSM/
ICD classification boundaries.
Conclusions
DSM-5 ASD criteria should be com-
mended for its clearer symptom descrip-
tions and grouping, for acknowledging the
spectrum nature of autism, and for
recognizing the dynamic nature of devel-
opment and how individuals interact with
their environment. Moreover, for clinical
purposes a unitary label of ASD may be
beneficial in planning the support systems
for all individuals ‘‘on the spectrum’’ who
require help from education and health-
and social-care systems. However, it is
important to remember that autism is not
homogenous, and defining it using the
umbrella term ASD risks whitewashing the
evident heterogeneity, which has a sub-
stantial impact for research into this
condition. The identification of core
features of autism using the broader ASD
label cannot overcome the existence of
heterogeneity. It has simply moved us
from the level of subgroups (‘‘apples and
oranges’’) to the prototypical level
(‘‘fruit’’). We argue that to make progress
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Table 1. A preliminary expanded (but nonexhaustive) list of specifiers, toward the identification of subgroups.
Category Specifier Example
Developmental pattern Pattern of atypical development 1. Age and pattern of onset/regression
2. Trajectory of development
3. Language onset
4. Hyperlexia
Sex/gender Biological sex Male/female
Sex/gender-adjusted autistic features Statistical characterization of autistic trait (e.g., percentile) relative to sex/gender-
specific norms
Clinical phenotype Co-occurring condition 1. Epilepsy
2. Macrocephaly
3. Gastrointestinal disorders
4. Immune disorders
5. Hyperserotonemia
6. Attention deficit/hyperactivity disorder
7. Anxiety disorders
8. Depressive disorders
9. Tics/Gilles de la Tourette syndrome
10. Obsessive-compulsive disorder
11. Schizophrenia spectrum
12. Dyslexia
13. Personality disorders
14. Self-injurious behaviors
15. Sleep disruption
16. Eating disorders
17. Gender dysphoria
Taxonomic formulation 1. Asperger syndrome
2. ‘‘Aloof’’/‘‘passive’’/‘‘active but odd’’/‘‘loners’’ groups
Motor abnormality 1. Types of motor stereotypy
2. Coordination disorder
3. Dyspraxia
Cognitive profile Intelligence 1. IQ profile (including discrepancy among subtests)
2. Savant memory
3. Savant spatial skills
Current language (structural properties) 1. Phonological/phonetic processing (including articulation)
2. Prosodic processing
3. Morphological processing
4. Syntactic processing
5. Semantic processing
6. Receptive vs. expressive abilities
Social cognition 1. Emotion perception and understanding
2. Face recognition
3. Emotional contagion
4. Social orienting
5. Social and nonsocial reward processing
6. Affective empathy
7. Sympathy
8. Joint attention
9. Pretend play
10. Theory of mind/mental perspective taking
11. Self-referential cognition
12. Alexithymia
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in autism research, and ultimately to
improve clinical practice, we need to move
forward in the identification of subgroups
within the autism spectrum.
Toward this end, we have expanded the
list of possible dimensional and categorical
‘‘specifiers’’ to improve our recognition of
‘‘the autisms.’’ In addition, it is important
to clarify the different definitions of the
term ‘‘spectrum.’’ Given that the spectrum
extends into the general population,
research needs to address the relation-
ship between cardinal autistic symptoms
and associated autistic traits (such as
excellent attention to detail). Finally, we
need to be fully aware of the inherent
limitations of the existing psychiatric
diagnostic systems, and consider other
approaches that may be beneficial for
research purposes [68].
The practical implication of the argu-
ments proposed in this article is that
parallel behavioral characterization systems may
be necessary for autism research from now
on. Although DSM-5-based diagnoses are
expected to be widely accepted by re-
searchers, a list of specifiers (including and
beyond those recommended here) to aid
phenotypic characterization will prevent
us from losing sight of ‘‘the autisms.’’ In a
Table 1. Cont.
Category Specifier Example
13. Metacognitive awareness
Executive function 1. Cognitive flexibility
2. Planning
3. Inhibitory control
4. Attention shifting
5. Working memory
6. Time perception
Bottom-up perceptual processing 1. Global-local perceptual processing
2. Low-level perceptual function and discrimination
3. Synesthesia
Top-down information processing 1. ‘‘Central coherence’’ (global-local contextual processing)
2. ‘‘Systemizing’’ (drive to construct rule-based systems, ability to understand rule-
based systems, knowledge of factual systems)
Genetics Syndromic autism 1. Fragile X syndrome
2. Rett syndrome
3. Tuberous sclerosis complex
4. Timothy syndrome
5. Down syndrome
6. Phenylketonuria
7. CHARGE syndrome
8. Angelman syndrome
9. PTEN macrocephaly syndrome
10. Joubert syndrome
11. Landau-Kleffner syndrome
12. Prader-Willi syndrome
13. Smith-Lemli-Opitz syndrome
14. Neurofibromatosis
Familial aggregation Simplex vs. multiplex
Gene-level variations e.g., ASTN2, AVPR1A, CACNA1C, CACNA1G, CDH8, CDH9, CDH10, CNTN4, CNTNAP2,
DISC1, DPP6, DPYD, EN2 (Engrailed 2), FMR1, FOXP2, GABRA4, GABRB3, GluR6, GRIK2,
GSTP1, HOXA1, HOXB1, ITGB3, MACROD2, MADCAM1, MAPK3, MBD5, MECP2, MET,
NLGN3, NLGN4X, NRXN1, NRXN3, OXTR, PRKCB1, PRL, PRLR, PTCHD1/PTCHD1AS,
PTEN, RELN (Reelin), SEMA5A, SERT (SLC6A4), SHANK1, SHANK2, SHANK3 (ProSAP2),
SLC25A12, TSC1, TSC2, UBE3A
Copy number variations (CNVs) (specify known ASD-association status, genetic loci, and deletion/duplication)
Environmental risks Social deprivation Early social isolation or neglect*
*(specify timing: postnatal months X to Y)
Environmental risk factor exposure 1. Rubella virus infection during gestation*
2. Valproic acid exposure during gestation*
3. Antidepressant exposure during gestation*
*(specify timing: gestational weeks X to Y)
doi:10.1371/journal.pbio.1001544.t001
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world that is moving toward individual-
ized medicine, not incorporating infor-
mation about such specifiers will be a
backward step. Last but not least, in
order to provide the basis to compare
with the rich studies to date and to
accurately assess the impact of shifting
from DSM-IV to DSM-5, a parallel
record of DSM-IV diagnoses may be
helpful for both research and clinical
settings in which these issues are partic-
ularly of concern.
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